Found: 72
Select item for more details and to access through your institution.
Gallium-68-Labeled KISS1-54 Peptide for Mapping KISS1 Receptor via PET: Initial Evaluation in Human Tumor Cell Lines and in Tumor-Bearing Mice.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 1, p. 44, doi. 10.3390/ph17010044
- By:
- Publication type:
- Article
A new concept for the production of <sup>11</sup>C-labelled radiotracers.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2022, v. 7, n. 1, p. 1, doi. 10.1186/s41181-022-00159-y
- By:
- Publication type:
- Article
Analysis of cerebral glucose metabolism following experimental subarachnoid hemorrhage over 7 days.
- Published in:
- Scientific Reports, 2023, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-26183-1
- By:
- Publication type:
- Article
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00213
- By:
- Publication type:
- Article
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00213
- By:
- Publication type:
- Article
[<sup>11</sup>C]Methionine emerges as a new biomarker for tracking active myeloma lesions.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 701, doi. 10.1111/bjh.14696
- By:
- Publication type:
- Article
Tumor-Associated Macrophages in Glioblastoma Multiforme—A Suitable Target for Somatostatin Receptor-Based Imaging and Therapy?
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0122269
- By:
- Publication type:
- Article
Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084840
- By:
- Publication type:
- Article
Is the Image Quality of I-124-PET Impaired by an Automatic Correction of Prompt Gammas?
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071729
- By:
- Publication type:
- Article
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
- Published in:
- Radiation Oncology, 2012, v. 7, n. 1, p. 99, doi. 10.1186/1748-717X-7-99
- By:
- Publication type:
- Article
3-Deaza-2′-deoxyadenosine: Synthesis via 4-(methylthio)-1 H-imidazo[4,5- c]pyridine 2′-deoxyribonucleosides and properties of oligonucleotides.
- Published in:
- Helvetica Chimica Acta, 1992, v. 75, n. 5, p. 1639, doi. 10.1002/hlca.19920750519
- By:
- Publication type:
- Article
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma.
- Published in:
- Molecular Imaging & Biology, 2024, v. 26, n. 5, p. 774, doi. 10.1007/s11307-024-01940-y
- By:
- Publication type:
- Article
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2399, doi. 10.3390/cancers12092399
- By:
- Publication type:
- Article
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2333, doi. 10.3390/cancers12082333
- By:
- Publication type:
- Article
18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1042, doi. 10.3390/cancers12041042
- By:
- Publication type:
- Article
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers.
- Published in:
- Brain: A Journal of Neurology, 2014, v. 137, n. 9, p. 2480, doi. 10.1093/brain/awu179
- By:
- Publication type:
- Article
Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
- Published in:
- Brain: A Journal of Neurology, 2006, v. 129, n. 5, p. 1188, doi. 10.1093/brain/awl042
- By:
- Publication type:
- Article
Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
- Published in:
- Brain: A Journal of Neurology, 2006, v. 129, n. 5, p. 1188, doi. 10.1093/brain/awl042
- By:
- Publication type:
- Article
The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 6, p. 1097, doi. 10.1007/s00259-017-3656-x
- By:
- Publication type:
- Article
Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 3, p. 553, doi. 10.1007/s00259-016-3566-3
- By:
- Publication type:
- Article
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 8, p. 1284, doi. 10.1007/s00259-012-2124-x
- By:
- Publication type:
- Article
Prospective study of p-[I]iodo- L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 12, p. 2344, doi. 10.1007/s00259-010-1572-4
- By:
- Publication type:
- Article
Intra-individual comparison of p-[<sup>123</sup>I]-iodo-L-phenylalanine and L-3-[<sup>123</sup>I]-iodo-α-methyl-tyrosine for SPECT imaging of gliomas.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 1, p. 24, doi. 10.1007/s00259-007-0514-2
- By:
- Publication type:
- Article
Validation of brain tumour imaging with p-[<sup>123</sup>I]iodo- l-phenylalanine and SPECT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 9, p. 1041, doi. 10.1007/s00259-005-1807-y
- By:
- Publication type:
- Article
p-[[sup 123]I]iodo-l-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 4, p. 532, doi. 10.1007/s00259-003-1445-1
- By:
- Publication type:
- Article
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 9, p. 632, doi. 10.1002/acn3.438
- By:
- Publication type:
- Article
Development and Validation of a Semi-Automated, Preclinical, MRI-Template Based PET Image Data Analysis Tool for Rodents.
- Published in:
- Frontiers in Neuroinformatics, 2021, v. 15, p. 1, doi. 10.3389/fninf.2021.639643
- By:
- Publication type:
- Article
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1889, doi. 10.2967/jnumed.123.266074
- By:
- Publication type:
- Article
Theranostics in Hematooncology.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1009, doi. 10.2967/jnumed.122.265199
- By:
- Publication type:
- Article
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 34, doi. 10.2967/jnumed.122.264207
- By:
- Publication type:
- Article
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1687, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264207
- By:
- Publication type:
- Article
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using <sup>68</sup>Ga-PentixaFor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264207
- By:
- Publication type:
- Article
maging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using <sup>68</sup>Ga-PentixaFor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264207
- By:
- Publication type:
- Article
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using 68Ga-PentixaFor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using <sup>68</sup>Ga-PentixaFor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using <sup>68</sup>Ga-PentixaFor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 23, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.257279
- By:
- Publication type:
- Article
Hexokinase-2 Expression in <sup> 11</sup>C-Methionine–Positive, <sup>18</sup>F-FDG–Negative Multiple Myeloma.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 348, doi. 10.2967/jnumed.118.217539
- By:
- Publication type:
- Article